مصطلحات الفهرس: convalescent plasma/dt [Drug Therapy], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], baloxavir marboxil/dt [Drug Therapy], baloxavir marboxil/pv [Special Situation for Pharmacovigilance], beta1a interferon/dt [Drug Therapy], beta1a interferon/pv [Special Situation for Pharmacovigilance], calcifediol/dt [Drug Therapy], calcifediol/pv [Special Situation for Pharmacovigilance], chloroquine/dt [Drug Therapy], chloroquine/pv [Special Situation for Pharmacovigilance], cobicistat plus darunavir/dt [Drug Therapy], cobicistat plus darunavir/pv [Special Situation for Pharmacovigilance], colchicine/dt [Drug Therapy], colchicine/pv [Special Situation for Pharmacovigilance], convalescent plasma/pv [Special Situation for Pharmacovigilance], corticosteroid/dt [Drug Therapy], corticosteroid/pv [Special Situation for Pharmacovigilance], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], daclatasvir/pv [Special Situation for Pharmacovigilance], dalteparin/dt [Drug Therapy], dalteparin/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], favipiravir/dt [Drug Therapy], favipiravir/pv [Special Situation for Pharmacovigilance], gamma interferon/dt [Drug Therapy], gamma interferon/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/pv [Special Situation for Pharmacovigilance], interferon beta serine/dt [Drug Therapy], interferon beta serine/pv [Special Situation for Pharmacovigilance], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], methylprednisolone/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], ruxolitinib/dt [Drug Therapy], ruxolitinib/pv [Special Situation for Pharmacovigilance], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], sofosbuvir/pv [Special Situation for Pharmacovigilance], telmisartan/dt [Drug Therapy], telmisartan/pv [Special Situation for Pharmacovigilance], umifenovir/dt [Drug Therapy], umifenovir/pv [Special Situation for Pharmacovigilance], face mask, dexamethasone/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], enoxaparin/dt [Drug Therapy], anticoagulant therapy, article, assisted ventilation, Australia, birth, breast feeding, clinical decision making, clinical trial (topic), clinician, controlled study, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/pc [Prevention], coronavirus disease 2019/th [Therapy], corticosteroid therapy, data collection method, data synthesis, disease surveillance, evidence based medicine, extracorporeal oxygenation, female, hand washing, human, maternal care, maternal hypertension/dt [Drug Therapy], mesenchymal stem cell transplantation, post exposure prophylaxis, practice guideline, pregnant woman, prenatal period, priority journal, prone position, puerperium, rooming in, skin, systematic review, thrombosis prevention, umbilical cord, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], aprepitant/dt [Drug Therapy], aprepitant/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28655Test
Australian and New Zealand Journal of Obstetrics and Gynaecology
Click here for full text options
LibKey Link

مصطلحات الفهرس: treatment contraindication, treatment indication, treatment response, azithromycin/ae [Adverse Drug Reaction], azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/dt [Drug Therapy], remdesivir/cb [Drug Combination], remdesivir/dt [Drug Therapy], letter, cardiotoxicity/si [Side Effect], coronavirus disease 2019/dt [Drug Therapy], early intervention, evidence based medicine, health care planning, high risk patient, human, infection control, outpatient care, pneumonia, QT prolongation/si [Side Effect], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27208Test
American Journal of Epidemiology
Click here for full text options
LibKey Link

مصطلحات الفهرس: convalescent plasma/dt [Drug Therapy], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], baloxavir marboxil/dt [Drug Therapy], baloxavir marboxil/pv [Special Situation for Pharmacovigilance], beta1a interferon/dt [Drug Therapy], beta1a interferon/pv [Special Situation for Pharmacovigilance], calcifediol/dt [Drug Therapy], calcifediol/pv [Special Situation for Pharmacovigilance], chloroquine/dt [Drug Therapy], chloroquine/pv [Special Situation for Pharmacovigilance], cobicistat plus darunavir/dt [Drug Therapy], cobicistat plus darunavir/pv [Special Situation for Pharmacovigilance], colchicine/dt [Drug Therapy], colchicine/pv [Special Situation for Pharmacovigilance], convalescent plasma/pv [Special Situation for Pharmacovigilance], corticosteroid/dt [Drug Therapy], corticosteroid/pv [Special Situation for Pharmacovigilance], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], daclatasvir/pv [Special Situation for Pharmacovigilance], dalteparin/dt [Drug Therapy], dalteparin/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], favipiravir/dt [Drug Therapy], favipiravir/pv [Special Situation for Pharmacovigilance], gamma interferon/dt [Drug Therapy], gamma interferon/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/pv [Special Situation for Pharmacovigilance], interferon beta serine/dt [Drug Therapy], interferon beta serine/pv [Special Situation for Pharmacovigilance], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], methylprednisolone/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], ruxolitinib/dt [Drug Therapy], ruxolitinib/pv [Special Situation for Pharmacovigilance], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], sofosbuvir/pv [Special Situation for Pharmacovigilance], telmisartan/dt [Drug Therapy], telmisartan/pv [Special Situation for Pharmacovigilance], umifenovir/dt [Drug Therapy], umifenovir/pv [Special Situation for Pharmacovigilance], face mask, dexamethasone/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], enoxaparin/dt [Drug Therapy], anticoagulant therapy, article, assisted ventilation, Australia, birth, breast feeding, clinical decision making, clinical trial (topic), clinician, controlled study, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/pc [Prevention], coronavirus disease 2019/th [Therapy], corticosteroid therapy, data collection method, data synthesis, disease surveillance, evidence based medicine, extracorporeal oxygenation, female, hand washing, human, maternal care, maternal hypertension/dt [Drug Therapy], mesenchymal stem cell transplantation, post exposure prophylaxis, practice guideline, pregnant woman, prenatal period, priority journal, prone position, puerperium, rooming in, skin, systematic review, thrombosis prevention, umbilical cord, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], aprepitant/dt [Drug Therapy], aprepitant/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28655Test
Australian and New Zealand Journal of Obstetrics and Gynaecology
LibKey Link

مصطلحات الفهرس: treatment contraindication, treatment indication, treatment response, azithromycin/ae [Adverse Drug Reaction], azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/dt [Drug Therapy], remdesivir/cb [Drug Combination], remdesivir/dt [Drug Therapy], letter, cardiotoxicity/si [Side Effect], coronavirus disease 2019/dt [Drug Therapy], early intervention, evidence based medicine, health care planning, high risk patient, human, infection control, outpatient care, pneumonia, QT prolongation/si [Side Effect], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27208Test
American Journal of Epidemiology
LibKey Link

مصطلحات الفهرس: exercise test, health care personnel, health service, heart electrophysiology, heart infarction, heart injury, heart pacing, human, New Zealand, nonhuman, pandemic, community care, coronary angiography, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/ep [Epidemiology], troponin/ec [Endogenous Compound], article, Australia, cardiac imaging, cardiovascular disease/di [Diagnosis], cardiovascular disease/dt [Drug Therapy], cardiovascular disease/su [Surgery], cardiovascular disease/th [Therapy], consensus, primary medical care, resuscitation, Severe acute respiratory syndrome coronavirus 2, telehealth, thorax surgery, transesophageal echocardiography, transthoracic echocardiography, angiotensin receptor antagonist/dt [Drug Therapy], azithromycin/dt [Drug Therapy], chloroquine/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], lopinavir plus ritonavir/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29181Test
Medical Journal of Australia
Click here for full text options
LibKey Link

مصطلحات الفهرس: SLEDAI, social status, systemic lupus erythematosus/dt [Drug Therapy], autoantibody/ec [Endogenous Compound], azathioprine/dt [Drug Therapy], beta2 glycoprotein 1 antibody/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], double stranded DNA antibody/ec [Endogenous Compound], hydroxychloroquine/dt [Drug Therapy], La antibody/ec [Endogenous Compound], leflunomide/dt [Drug Therapy], lupus anticoagulant/ec [Endogenous Compound], mercaptopurine/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], neutrophil cytoplasmic antibody/ec [Endogenous Compound], phospholipid antibody/ec [Endogenous Compound], prednisolone/dt [Drug Therapy], rheumatoid factor/ec [Endogenous Compound], ribonucleoprotein antibody/ec [Endogenous Compound], Sm antibody/ec [Endogenous Compound], high disease activity status, adult, article, clinical feature, clinical outcome, comparative study, corticosteroid therapy, demography, disease activity, disease activity score, disease severity, female, human, major clinical study, male, middle aged, observational study, physician, priority journal, scoring system, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29232Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: letter, medical history, middle aged, nausea/si [Side Effect], repeated drug dose, retreatment, skin defect, skin granuloma/di [Diagnosis], skin granuloma/dr [Drug Resistance], skin granuloma/dt [Drug Therapy], skin infiltrate/di [Diagnosis], sunlight protection, corticosteroid/dt [Drug Therapy], corticosteroid/tp [Topical Drug Administration], corticosteroid/tm [Unexpected Outcome of Drug Treatment], cyclosporine/ae [Adverse Drug Reaction], cyclosporine/dt [Drug Therapy], etretin/ae [Adverse Drug Reaction], etretin/do [Drug Dose], etretin/dt [Drug Therapy], etretin/po [Oral Drug Administration], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/tm [Unexpected Outcome of Drug Treatment], methotrexate/dt [Drug Therapy], methotrexate/tm [Unexpected Outcome of Drug Treatment], sunscreen, triamcinolone/dt [Drug Therapy], triamcinolone/il [Intralesional Drug Administration], actinic granuloma/di [Diagnosis], actinic granuloma/dr [Drug Resistance], actinic granuloma/dt [Drug Therapy], female, adult, biopsy, case report, clinical article, dose response, drug substitution, drug withdrawal, dry skin/si [Side Effect], erythema, giant cell, human, human tissue, inflammatory infiltrate, Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35478Test
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

مصطلحات الفهرس: breast cancer, cancer incidence, cancer mortality, cancer patient, cancer risk, cancer survival, cohort analysis, controlled study, disease burden, female, health care cost, health care utilization, hematologic malignancy, human, lung cancer, major clinical study, malignant neoplasm/dt [Drug Therapy], melanoma, proportional hazards model, prospective study, risk factor, standardized incidence ratio, systemic sclerosis/di [Diagnosis], systemic sclerosis/dm [Disease Management], systemic sclerosis/dt [Drug Therapy], treatment outcome, abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], calcium channel blocking agent/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], DNA directed RNA polymerase III/ec [Endogenous Compound], hydroxychloroquine/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolate mofetil/dt [Drug Therapy], rituximab/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], male, adult, article, Australian, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28980Test
Arthritis Care and Research
Click here for full text options
LibKey Link

مصطلحات الفهرس: single drug dose, staphylococcal bacteremia/dt [Drug Therapy], staphylococcal bacteremia/si [Side Effect], ventilator associated pneumonia/dt [Drug Therapy], ventilator associated pneumonia/si [Side Effect], Victoria, virus pneumonia/dt [Drug Therapy], azithromycin/cb [Drug Combination], azithromycin/pv [Special Situation for Pharmacovigilance], C reactive protein/ec [Endogenous Compound], ceftriaxone/cb [Drug Combination], ceftriaxone/pv [Special Situation for Pharmacovigilance], ferritin/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/cb [Drug Combination], hydroxychloroquine/dt [Drug Therapy], lopinavir plus ritonavir/ae [Adverse Drug Reaction], lopinavir plus ritonavir/cb [Drug Combination], lopinavir plus ritonavir/dt [Drug Therapy], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], noradrenalin/cb [Drug Combination], piperacillin plus tazobactam/cb [Drug Combination], piperacillin plus tazobactam/dt [Drug Therapy], piperacillin plus tazobactam/iv [Intravenous Drug Administration], prednisone/cb [Drug Combination], prednisone/dt [Drug Therapy], prednisone/po [Oral Drug Administration], prednisone/pv [Special Situation for Pharmacovigilance], tocilizumab/ae [Adverse Drug Reaction], tocilizumab/cb [Drug Combination], tocilizumab/iv [Intravenous Drug Administration], tocilizumab/pv [Special Situation for Pharmacovigilance], vancomycin/dt [Drug Therapy], vancomycin/iv [Intravenous Drug Administration], fraction of inspired oxygen, tocilizumab/dt [Drug Therapy], acute kidney failure/th [Therapy], adult, aged, article, artificial ventilation, Australian, catheter removal, clinical article, coronavirus disease 2019/dt [Drug Therapy], cytokine release syndrome/dt [Drug Therapy], delirium/si [Side Effect], drug withdrawal, endotracheal intubation, eosinophilia/si [Side Effect], extubation, fatty liver, fever, hepatitis/si [Side Effect], human, hypoxia, intensive care, kidney failure/si [Side Effect], male, middle aged, myositis/si [Side Effect], New South Wales, open study, oxygen saturation, oxygen therapy, priority journal, prone position, QT prolongation/si [Side Effect], respiratory failure/th [Therapy], respiratory tract parameters, retrospective study, sedation, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28864Test
International Journal of Rheumatic Diseases
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375Test
Australasian Journal of Dermatology
Click here for full text options
LibKey Link